Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroleptic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT00567099
What this trial is testing

Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole

Who this might be right for
SchizophreniaSensory Gating
New Mexico VA Healthcare System 20
Early research (Phase 1)Study completedNCT02051387
What this trial is testing

Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 74
Not applicableLooking for participantsNCT05783063
What this trial is testing

ITBS for Increased Appetite Induced by Antipsychotics

Who this might be right for
Schizophrenia
Central South University 60
Not applicableStudy completedNCT00328952
What this trial is testing

Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With Schizophrenia

Who this might be right for
SchizophreniaHallucinations
Seoul National University Hospital 40
Large-scale testing (Phase 3)Study completedNCT01432444
What this trial is testing

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 493
Early research (Phase 1)Study completedNCT01495169
What this trial is testing

Tolerability and Pharmacokinetics of Iloperidone in Adolescent Patients

Who this might be right for
Safety and Tolerability of Iloperidone
Vanda Pharmaceuticals 33
Testing effectiveness (Phase 2)Study completedNCT00816894
What this trial is testing

D-serine Monotherapy for Schizophrenia

Who this might be right for
Schizophrenia
Herzog Hospital 18
Not applicableUnknownNCT01215383
What this trial is testing

The Antiatherogenic Properties of HDL in Psychiatric Patients With and Without Antipsychotic Therapy

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder
Ziv Hospital 20
Not applicableStudy completedNCT00888264
What this trial is testing

A NIS Evaluating the Treatment Patterns of Atypical Antipsychotics in Patients Diagnosed With Bipolar I or II Disorder

Who this might be right for
Bipolar Disorders
AstraZeneca 152
Not applicableStudy completedNCT01976793
What this trial is testing

Retrospective Observational Study DIANA Study

Who this might be right for
Major Depressive Episode
AstraZeneca 450
Large-scale testing (Phase 3)Study completedNCT00297388
What this trial is testing

How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder

Who this might be right for
SchizophreniaSchizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Not applicableLooking for participantsNCT05951660
What this trial is testing

Sex, Psychopharmacology, and Diabetes

Who this might be right for
SchizophreniaSchizophrenia Spectrum and Other Psychotic DisordersDiabetes Mellitus+4 more
Zealand University Hospital 256
Not applicableStudy completedNCT00597168
What this trial is testing

Quality of Life in Schizophrenic Patients

Who this might be right for
Schizophrenia
AstraZeneca 124
Large-scale testing (Phase 3)Study completedNCT00210717
What this trial is testing

Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 748
Not applicableUnknownNCT06238089
What this trial is testing

Anti-psychotic Drug Prescribing Patterns Within Specialist Adult ID Services in England and Wales

Who this might be right for
Intellectual Disability
University of Plymouth 600
Early research (Phase 1)Study completedNCT00892489
What this trial is testing

A Bioequivalence Study of 15 mg ER OROS Paliperidone

Who this might be right for
Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Not applicableStudy completedNCT01686815
What this trial is testing

Cross-Sectional Iloperidone IVGTT

Who this might be right for
SchizophreniaSerious Mental IllnessMetabolic Syndrome+2 more
Massachusetts General Hospital 37
Testing effectiveness (Phase 2)Study completedNCT01499563
What this trial is testing

Study of a Novel Antipsychotic ITI-007 in Schizophrenia

Who this might be right for
Schizophrenia
Intra-Cellular Therapies, Inc. 335
Post-approval studies (Phase 4)Study completedNCT00895921
What this trial is testing

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

Who this might be right for
Diabetes
Veterans Medical Research Foundation 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT02926859
What this trial is testing

Enhancing Recovery in Early Schizophrenia

Who this might be right for
Schizophrenia
Central Institute of Mental Health, Mannheim 180
Next Page